Abbott RealTime IDH2
U.S. real-time PCR assay for source-scoped IDH2 mutation testing in acute myeloid leukemia.
- Developer
- Abbott Molecular
- Intended use
- Other
- Cancer scope
- Acute myeloid leukemia
- Specimen
- Bone marrow aspirate, Whole blood
- Molecular modality
- DNA mutation
- Current version
- Abbott RealTime IDH2 REF 08N82-090, package-insert revision R1; nine IDH2 mutations
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.